Ex­clu­sive: Sidu­ma, a biotech from Arv­inas' sci­en­tif­ic founder, shut­ters due to 'fi­nanc­ing en­vi­ron­men­t'

Sidu­ma Ther­a­peu­tics, a Yale spin­out from Arv­inas sci­en­tif­ic founder Craig Crews, has closed, a spokesper­son for the com­pa­ny con­firmed to End­points News via email Thurs­day.

“In re­sponse to the chal­leng­ing fund­ing en­vi­ron­ment for ear­ly-stage sci­ence, Sidu­ma Ther­a­peu­tics’ lead­er­ship has made the dif­fi­cult de­ci­sion to sus­pend op­er­a­tions and re­turn in­vest­ment back to our share­hold­ers,” the spokesper­son wrote.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER